Clinical Trial Results: Trial of ARV-110 and Abiraterone in Participants With Metastatic Prostate Cancer [Phase 1]

View source ↗

Summary

Phase 1 trial results of ARV-110 combined with Abiraterone in metastatic prostate cancer were completed and results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Prostate Cancer

Drugs mentioned

• ARV-110 (ARV-110)
• Abiraterone (abiraterone)

Snippet

Sponsor: Arvinas Androgen Receptor, Inc. | Conditions: Prostate Cancer Metastatic | Phase 1 | Status: COMPLETED | Results posted: 2026-04-28